PerkinElmer received FDA Emergency Use Authorization for respiratory SARS-CoV-2 panel
On Oct. 7, 2021, PerkinElmer announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use…
-
-
Duke University-led study showed Vaxart’s oral COVID-19 vaccine candidate reduced transmission of SARS-CoV-2 infection
On Oct. 7, 2021, Vaxart announced that a Duke University-led study published in bioRxiv showed that Vaxart’s (investigational…
-
Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per year
On Oct. 7, 2021, Moderna announced it will build a state-of-the-art mRNA facility in Africa with the goal…
-
WHO, UN set out steps to meet world COVID vaccination targets
On Oct. 7, 2021, the World Health Organization (WHO) launched the Strategy to Achieve Global Covid-19 Vaccination by…
-
Washington University School of Medicine in St. Louis led pediatric COVID-19 vaccine trial launched
On Oct. 6, 2021, Washington University School of Medicine announced the start of a pediatric COVID-19 vaccine clinical…
-
WHO recommended groundbreaking malaria vaccine for children at risk
On Oct. 6, 2021, the World Health Organization (WHO) recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine…
-
Lumen Bioscience awarded Federal funding to advance Covid-19 antibody cocktail through phase 2 clinical evaluation
On Oct. 6, 2021, Lumen Bioscience announced new development funding from the US Army for its Covid-19 monoclonal…
-
NIH researchers linked depression during pregnancy to placental gene modifications
On Oct. 6, 2021, a study by researchers at the National Institutes of Health (NIH) found that episodes…
-
NIH BRAIN Initiative unveiled detailed Atlas of the Mammalian Primary Motor Cortex
On Oct. 6, 2021, the National Institutes of Health Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Cell…
-
Vaxartﾠ began recruiting in global phase II COVID-19 oral tablet vaccine clinical trial
On Oct. 6, 2021, Vaxart announced that it had begun recruiting subjects for its Phase II COVID-19 oral…
-
AIM ImmunoTech published phase 1 clinical study data supporting the safety of Ampligen as intranasal therapy
On Oct. 6, 2021, AIM ImmunoTech released detailed safety data from a Phase 1 clinical study which supported…
-
Moderna announced EMA authorized third dose of COVID-19 vaccine for immunocompromised individuals aged 12 years and older
On Oct. 5, 2021, Moderna announced that the European Medicines Agency (EMA) had authorized a third dose of…
-
Johnson & Johnson submitted EUA amendment to FDA to support booster of single-shot COVID-19 vaccine
On Oct. 5, 2021, Johnson & Johnson announced it had submitted data to the U.S. Food and Drug…
-
Vaccination linked reduction of over a quarter million COVID-19 cases, 100,000 hospitalizations, and 39,000 deaths among seniors
On Oct. 5, 2021, a report from the U.S. Department of Health and Human Services (HHS) showed that…
-
Biotechnology | NIH | Oncology | Therapeutics
the Fred & Pamela Buffett Cancer Center received NCI designated cancer center renewal
On Oct. 4, 2021, the Fred & Pamela Buffett Cancer Center announced it had successfully renewed its National…
-
World’s oldest evidence for the earliest small-scale plant cultivation was discovered
World’s oldest evidence dating to 23000 BCE for the earliest small-scale plant cultivation was discovered by Dani Nadel…
-
Farmers in China, Egypt and Sumeria began using fermentation
Around 8000 BCE, farmers in China, Egypt and Sumeria began using fermentation to produce cheese and wine. One…
-
Earliest known evidence of cheese making found in Croatia, Poland and Switzerland
Earliest known evidence of cheese making was found in Croatia dated to 7200 BCE. Residues from sherds of…
-
Earliest physical trace of beer found at a site called Godin Tepe
The earliest physical trace of beer dates back to the late fourth millennium BC in present day Iran…
-
Chinese healers created the first antibiotic to treat boils
Around 600 BCE, Chinese healers created the first antibiotic – moldy soybean curds – to treat boils.
-
Hippocrates described mumps, diphtheria, epidemic jaundice, and other conditions
Around 500 BCE, Hippocrates, a pioneering physician in the history of Medicine, and considered as the principal author…
-
Chinese growers used powdered chrysanthemum (pyrethrins) as the first insecticide
Around 100 BCE, Chinese growers used powdered chrysanthemum (pyrethrins) as the first insecticide.
-
The 2021 Nobel Prize in Physiology or Medicine was awarded to David Julius and Ardem Patapoutian ‘for their discoveries of receptors for temperature and touch’
On Oct. 4, 2021, the Nobel Prize in Physiology or Medicine was awarded to David Julius and Ardem…
-
Dynavax and U.S. Department of Defense announce collaboration to develop adjuvanted plague vaccine
On Oct. 4, 2021, Dynavax Technologies and the U.S. Department of Defense (DOD) announced Dynavax has executed an…
-
Pfizer and BioNTech received CHMP positive opinion for COVID-19 vaccine booster in the European Union
On Oct. 4, 2021, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
-
Biotechnology | CDC | COVID-19 | EPA | FDA | Infectious Disease | U.S. Congress | USDA | Vaccine
US Department of Defense announced mandatory coronavirus disease 2019 vaccination of civilian employees
On Oct. 4, 2021, the the Secretary of Defense directed the mandatory vaccination of Service members against the…
-
Biotechnology | COVID-19 | Diagnostics | FDA
ACON’s Flowflex COVID-19 home test received FDA EUA
On Oct. 4, 2021, ACON Laboratories announced that its Flowflex COVID-19 Antigen Home Test had been authorized for…
-
Merck and Ridgeback’s oral antiviral reduced risk of hospitalization or death for patients with COVID-19 in positive phase 3 study
On Oct. 1, 2021, Merck and Ridgeback Biotherapeutics announced that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine,…
-
Labcorp received EUA for at home collection kit for combined COVID-19 and flu detection
On Oct. 1, 2021, LabCorp announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…
-
Biotechnology | FDA | Oncology | Therapeutics
FDA approved Kite’s Tecartus as first and only Car T for adults with Relapsed or Refractory B-cell ALL
On Oct. 1, 2021, Kite, a Gilead Company, announced the U.S. Food and Drug Administration (FDA) has granted…
